The Medical Advisor

OneDayMD • The Medical Advisor A single starting point for exploring OneDayMD's health, wellness, longevity, nutrition, cancer, metabolic medicine, emerging therapies and digital-health research. Quick Answer OneDayMD is an independent health-information and research-synthesis platform covering conventional medicine, integrative health, longevity, nutrition, supplements, metabolic medicine, cancer research, emerging therapies and digital health. This Master Guide is the site's central navigation page: use it to find the right topic hub, then move from a broad guide to the specific evidence, study, therapy, supplement, condition or research question you are investigating. On this page Start Here · Core Health Hubs · Cancer & Oncology · Nutrition & Supplements · Longevity · GLP-1 & Metabolic Health · DMSO ·...

By Dr. Frank Yap, MD · One Day Media Network · Published September 24, 2026 · Updated October 9, 2026 · Data current to this date GLP-1-based medicines such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) often cause gastrointestinal symptoms that are manageable, but they also carry warnings for uncommon, potentially serious adverse events. The most useful way to read GLP-1 safety is to sort symptoms into three groups: emergency , urgent and common . Quick Answer GLP-1 medicines such as semaglutide and tirzepatide mostly cause manageable gastrointestinal symptoms (nausea, diarrhea, constipation). Emergency care is needed for breathing difficulty, facial or throat swelling, severe hypoglycemia with confusion, fainting from dehydration, severe or worsening abdominal pain, or sudden vision loss. Persistent vomiting, severe constipation or possible gallbladder symptoms need prompt same-day medical contact. In an emergency, do not rely on this art...